Periodic safety reporting schedule
Active Substances | Trade Name | MAH | Year of registration in Saudi Arabia | International Birth Date (IBD) | PSUR Submission Frequency | Data Lock Point (DLP) | Submission Date |
---|---|---|---|---|---|---|---|
Diclofenac sodium | Voltaren Gastro-resistant tablet | NOVARTIS | 3 years | ||||
DICLOFENAC SODIUM | DICLAC | SANDOZ | 3 Years | ||||
Diclofenac sodium | Voltaren Modified-release tablet | NOVARTIS | 3 years | ||||
Diclofenac sodium | Voltaren Ophtha CD Eye drops | NOVARTIS | 3 years | ||||
Diclofenac sodium | Voltaren Solution for injection | NOVARTIS | 3 years | ||||
Indacaterol Maleate | Ultibro Breezhaler | NOVARTIS | annual | ||||
OCRELIZUMAB | Ocrevus | ROCHE | 6 months | ||||
Denosumab | Xgeva | AMGEN | Annual | ||||
Denosumab | Prolia | AMGEN | Annual | ||||
Measles / mumps / rubella / varicella vaccines (live) | PRIORIX-TETRA | GLAXOSMITHKLINE (GSK) | 3 years |